Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation

scientific article published on 17 May 2014

Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.HEALUN.2014.02.033
P698PubMed publication ID24954882
P5875ResearchGate publication ID262453759

P2093author name stringMargaret M Burke
Marlene L Rose
Martin Carby
Simona Soresi
Anna J Danskine
Helen Newell
John D Smith
Mohamed W Ibrahim
P433issue10
P921main subjectantibodyQ79460
lung transplantQ1637912
P304page(s)1074-1082
P577publication date2014-05-17
P1433published inThe Journal of Heart and Lung TransplantationQ2364382
P1476titlePre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation
P478volume33

Reverse relations

cites work (P2860)
Q47744928Acute rejection
Q36302476An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA
Q92120781Antibody-Mediated Rejection in a Multiple Lung Transplant Patient: A Case Report
Q94476124Antibody-mediated rejection after lung transplantation
Q46970385Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment
Q54969814Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.
Q88663316Contemporary Strategies and Barriers to Transplantation Tolerance
Q64263915Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff
Q37590820From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.
Q50247563HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction
Q42364236IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation
Q91936186Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation
Q55547403New frontiers in immunosuppression.
Q88543841Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation
Q51764178Preformed donor-specific HLA antibodies are associated with increased risk of early mortality after liver transplantation.
Q53079577Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients.
Q39126171Repeated human leukocyte antigen mismatches in lung re-transplantation
Q51015580Survival in sensitized lung transplant recipients with perioperative desensitization.
Q36202595The impact of pre-transplant allosensitization on outcomes after lung transplantation
Q40634986Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss
Q45241825What is the definition of a clinically relevant donor HLA-specific antibody (DSA)?

Search more.